507 related articles for article (PubMed ID: 25603785)
21. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
Li CI; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
[TBL] [Abstract][Full Text] [Related]
22. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
23. The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
Polat AV; Soran A; Andacoglu O; Kamali Polat A; McGuire K; Diego E; Johnson R
J BUON; 2013; 18(3):601-7. PubMed ID: 24065470
[TBL] [Abstract][Full Text] [Related]
24. Predicting invasive breast cancer versus DCIS in different age groups.
Ayvaci MU; Alagoz O; Chhatwal J; Munoz del Rio A; Sickles EA; Nassif H; Kerlikowske K; Burnside ES
BMC Cancer; 2014 Aug; 14():584. PubMed ID: 25112586
[TBL] [Abstract][Full Text] [Related]
25. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
[TBL] [Abstract][Full Text] [Related]
26. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
[TBL] [Abstract][Full Text] [Related]
27. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
[TBL] [Abstract][Full Text] [Related]
28. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
Weaver DL; Vacek PM; Skelly JM; Geller BM
Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
[TBL] [Abstract][Full Text] [Related]
29. Benign breast biopsy diagnosis and subsequent risk of breast cancer.
Ashbeck EL; Rosenberg RD; Stauber PM; Key CR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):467-72. PubMed ID: 17337650
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
[TBL] [Abstract][Full Text] [Related]
31. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
Sprague BL; Chen S; Miglioretti DL; Gard CC; Tice JA; Hubbard RA; Aiello Bowles EJ; Kaufman PA; Kerlikowske K
JAMA Netw Open; 2023 Feb; 6(2):e230166. PubMed ID: 36808238
[TBL] [Abstract][Full Text] [Related]
32. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
[TBL] [Abstract][Full Text] [Related]
33. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
[TBL] [Abstract][Full Text] [Related]
34. MRI of occult breast carcinoma in a high-risk population.
Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
[TBL] [Abstract][Full Text] [Related]
35. Mammography surveillance following breast cancer.
Geller BM; Kerlikowske K; Carney PA; Abraham LA; Yankaskas BC; Taplin SH; Ballard-Barbash R; Dignan MB; Rosenberg R; Urban N; Barlow WE
Breast Cancer Res Treat; 2003 Sep; 81(2):107-15. PubMed ID: 14572153
[TBL] [Abstract][Full Text] [Related]
36. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of ductal carcinoma in situ.
Kerlikowske K
J Natl Cancer Inst Monogr; 2010; 2010(41):139-41. PubMed ID: 20956818
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving Surgery (BCS).
Gunia SR; Merrigan TL; Poulton TB; Mamounas EP
Ann Surg Oncol; 2012 Oct; 19(10):3139-43. PubMed ID: 22872291
[TBL] [Abstract][Full Text] [Related]
40. Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective.
Kumar AS; Bhatia V; Henderson IC
Breast Cancer Res; 2005; 7(6):271-5. PubMed ID: 16457703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
